Decoding DNA Just Got Faster: Dr. Lal PathLabs Enters the NovaSeq Era

Unknown Apr 02, 2026 900 Views

Dr. Lal PathLabs Ltd. (NSE: DLPA.NS), India's leading diagnostic chain, has taken its genomics game to the next level by adding Illumina's NovaSeq X Series—a next-generation, ultra-high-throughput sequencing platform. The addition places the company at the forefront of precision dia...